Sandoz restarted production at a sterile injectables plant in Canada late Sunday night and said it will soon lift a temporary allocation system after working…

The kingpin behind a scheme that sold $17 million worth of foreign-made cancer meds and other drugs--claiming that they were FDA approved--in the U.S. is going…

Sandoz Canada has suspended manufacturing at a sterile injectables plant in Canada and instituted what it calls a “proactive allocation system” after more than…

As some Big Pharma players have struggled in China recently, AstraZeneca has managed to keep up its double-digit sales growth there through the first quarter.…

Merck & Co. is facing another supply interruption for its ovulation-stimulating hormone Follistim, and like the supply lapse from several years ago, Merck…

Akorn and its Hi-Tech Pharmacal unit have had a number of recalls lately involving its liquid products, including more than 7,200 bottles of dental mouth rinse…

AstraZeneca has received a CRL tied to manufacturing issues that are delaying the potential approval of the drug candidate for which it ponied up $2.7 billion…

Scientists at MIT have a prototype of a continuous manufacturing device that is so small it might be used by pharmacies to produce their own generic drugs.

JHL Biotech is ready to start producing biologics at its new plant in Wuhan, a project that took 18 months from beginning to end to complete.